We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ekf Diagnostics Holdings Plc | LSE:EKF | London | Ordinary Share | GB0031509804 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.18% | 27.80 | 27.90 | 28.90 | 27.80 | 27.80 | 27.80 | 183,724 | 16:35:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 52.61M | 2.35M | 0.0052 | 53.46 | 126.47M |
From Apr 2019 to Apr 2024
TIDMEKF
RNS Number : 4054V
EKF Diagnostics Holdings PLC
15 April 2016
15 April 2016
EKF Diagnostics Holdings plc
(the "Company" or the "Borrower")
Notice of loan redemption
EKF Diagnostics Holdings plc (AIM: EKF) announces that it has served notice to redeem the GBP3 million convertible loan ("Convertible Loan") from Zwanziger Family Ventures LLC (the "Lender").
Under the terms of the convertible loan the Borrower is entitled to repay the entire Convertible Loan giving the Lender at least 20 days' notice. The Lender has the right to serve a conversion notice on the Borrower at any time giving not less than 10 days' notice. If the Convertible Loan is converted, at the option of the Lender, the conversion price per share is 14.4 pence per share (being a 20 per cent. premium to the Company's share price on 22 December 2015).
North Atlantic Smaller Companies Investment Trust PLC ("NAIT") has agreed to provide to a loan facility of GBP3 million to EKF with interest accruing a LIBOR plus 5%, payable every 6 months in arrears, with security over the assets of the Company ranking behind HSBC (the "Loan"). There is no early re-payment penalty or ability to convert into ordinary shares of the Company.
Christopher Mills as non-executive Chairman of the Company. Harwood Capital LLP is investment manager to NAIT. Harwood Capital LLP is a limited liability partnership of which Christopher Mills is a partner and Chief Investment Officer. Therefore the Loan constitutes a related party transaction. EKF's Directors, with the exception of Christopher Mills, consider, having consulted with its nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.
EKF Diagnostics Holdings Tel: 029 2071 0570 plc Julian Baines, CEO Richard Evans, FD & COO Panmure Gordon (UK) Tel: 020 7886 2500 Limited Robert Naylor (Corporate Finance) Paul Fincham (Corporate Finance) Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZELFFQZFEBBL
(END) Dow Jones Newswires
April 15, 2016 10:53 ET (14:53 GMT)
1 Year Ekf Diagnostics Chart |
1 Month Ekf Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
